Related Articles
Prognostic factors in resected pulmonary carcinoid tumors: A retrospective study with 10 years of follow‑up
Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients
Prognostic value of the immunohistochemistry markers CD56, TTF‑1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors
Impact of in vitro chemosensitivity test‑guided platinum‑based adjuvant chemotherapy on the surgical outcomes of patients with p‑stage IIIA non‑small cell lung cancer that underwent complete resection
Effects of p38MAPK‑mediated excision repair cross‑complementation 1 expression on prognosis of patients with non‑small cell lung cancer